Vir Biotechnology Stock Price Prediction
| VIR Stock | USD 8.13 0.03 0.37% |
Oversold Vs Overbought
39
Oversold | Overbought |
Vir Biotechnology stock price prediction is an act of determining the future value of Vir Biotechnology shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Vir Biotechnology's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Vir Biotechnology and does not consider all of the tangible or intangible factors available from Vir Biotechnology's fundamental data. We analyze noise-free headlines and recent hype associated with Vir Biotechnology, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Vir Biotechnology's stock price prediction:Quarterly Earnings Growth 0.585 | EPS Estimate Next Quarter (1.11) | EPS Estimate Current Year (4.10) | EPS Estimate Next Year (3.98) | Wall Street Target Price 32.29 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Vir Biotechnology based on different types of headlines from major news networks to social media. The Vir stock price prediction module provides an analysis of price elasticity to changes in media outlook on Vir Biotechnology over a specific investment horizon. Using Vir Biotechnology hype-based prediction, you can estimate the value of Vir Biotechnology from the perspective of Vir Biotechnology response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Vir Biotechnology using Vir Biotechnology's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Vir using crowd psychology based on the activity and movement of Vir Biotechnology's stock price.
Vir Biotechnology Implied Volatility | 69.89 |
Vir Biotechnology's implied volatility exposes the market's sentiment of Vir Biotechnology stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Vir Biotechnology's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Vir Biotechnology stock will not fluctuate a lot when Vir Biotechnology's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Vir Biotechnology. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Vir Biotechnology to buy its stock at a price that has no basis in reality. In that case, they are not buying Vir because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Vir Biotechnology after-hype prediction price | USD 8.1 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Vir |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vir Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vir Biotechnology After-Hype Price Prediction Density Analysis
As far as predicting the price of Vir Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vir Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vir Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vir Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Vir Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vir Biotechnology's historical news coverage. Vir Biotechnology's after-hype downside and upside margins for the prediction period are 4.65 and 11.55, respectively. We have considered Vir Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vir Biotechnology is not too volatile at this time. Analysis and calculation of next after-hype price of Vir Biotechnology is based on 3 months time horizon.
Vir Biotechnology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Vir Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vir Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vir Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 3.45 | 0.03 | 0.36 | 8 Events / Month | 10 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
8.13 | 8.10 | 0.37 |
|
Vir Biotechnology Hype Timeline
On the 23rd of April Vir Biotechnology is traded for 8.13. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of -0.36. Vir is forecasted to decline in value after the next headline, with the price expected to drop to 8.1. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -0.37%, whereas the daily expected return is at this time at -0.21%. The volatility of related hype on Vir Biotechnology is about 199.01%, with the expected price after the next announcement by competition of 7.77. About 14.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.76. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vir Biotechnology has Price/Earnings To Growth (PEG) ratio of 1.14. The entity recorded a loss per share of 4.59. The firm had not issued any dividends in recent years. Considering the 90-day investment horizon the next forecasted press release will be in about 8 days. Check out Vir Biotechnology Basic Forecasting Models to cross-verify your projections.Vir Biotechnology Related Hype Analysis
Having access to credible news sources related to Vir Biotechnology's direct competition is more important than ever and may enhance your ability to predict Vir Biotechnology's future price movements. Getting to know how Vir Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vir Biotechnology may potentially react to the hype associated with one of its peers.
Vir Biotechnology Additional Predictive Modules
Most predictive techniques to examine Vir price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vir using various technical indicators. When you analyze Vir charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Vir Biotechnology Predictive Indicators
The successful prediction of Vir Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vir Biotechnology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vir Biotechnology based on analysis of Vir Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vir Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vir Biotechnology's related companies. | 2023 | 2024 (projected) | Payables Turnover | 3.51 | 3.33 | Days Of Inventory On Hand | 42.86 | 38.1 |
Story Coverage note for Vir Biotechnology
The number of cover stories for Vir Biotechnology depends on current market conditions and Vir Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vir Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vir Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Vir Biotechnology Short Properties
Vir Biotechnology's future price predictability will typically decrease when Vir Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vir Biotechnology often depends not only on the future outlook of the potential Vir Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vir Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 134.1 M | |
| Cash And Short Term Investments | 1.5 B |
Check out Vir Biotechnology Basic Forecasting Models to cross-verify your projections. To learn how to invest in Vir Stock, please use our How to Invest in Vir Biotechnology guide.You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Vir Stock analysis
When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is Vir Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vir Biotechnology. If investors know Vir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vir Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.585 | Earnings Share (4.59) | Revenue Per Share 0.643 | Quarterly Revenue Growth (0.66) | Return On Assets (0.17) |
The market value of Vir Biotechnology is measured differently than its book value, which is the value of Vir that is recorded on the company's balance sheet. Investors also form their own opinion of Vir Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Vir Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vir Biotechnology's market value can be influenced by many factors that don't directly affect Vir Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vir Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vir Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vir Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.